CATHETER-BASED ARRAY FOR INTRACARDIAC ULTRASOUND IMAGING

Information

  • Research Project
  • 6074343
  • ApplicationId
    6074343
  • Core Project Number
    R43HL063583
  • Full Project Number
    1R43HL063583-01A1
  • Serial Number
    63583
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/15/2000 - 24 years ago
  • Project End Date
    8/14/2001 - 23 years ago
  • Program Officer Name
  • Budget Start Date
    2/15/2000 - 24 years ago
  • Budget End Date
    8/14/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    2/2/2000 - 24 years ago

CATHETER-BASED ARRAY FOR INTRACARDIAC ULTRASOUND IMAGING

Development of a cardiac catheter for intracardiac ultrasound diagnostic imaging is proposed for monitoring heart function in perioperative critical care settings where chest wall echo is unavailable; for anatomical and functional monitoring of cardiac catheterization interventions for coronary artery disease, valvular disease and congenital heart disease; and for monitoring, controlling cardiac arrhythmias by electrophysiologic or ablation therapies. Application of these devices would replace transesophageal echo in patients needing the above therapies. The goals of this Phase I application are to define the specifications, applicability, and commercial viability of new "high-risk" technologies applied toward the development of the OEM marketed intraluminal ultrasound probes for those companies in the commercial cardiac ultrasound market. Our probes will be designed for placement in the heart from which they would produce high resolution images of the entire heart or portions of it as well as ablation procedures used for Doppler flow information. PROPOSED COMMERCIAL APPLICATIONS: This intracardiac ultrasound imaging catheter is to be an OEM product intended to reside as a feature within a full-capability, color Doppler, high- end echocardiography machine. The catheter is to be capable of monitoring heart function as well as catheter interventions. This functionality matches that of current transesophageal methods but will provide higher resolution.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    180419
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:180419\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MICROHELIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PORTLAND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    97224
  • Organization District
    UNITED STATES